Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, May 5, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
KEYTRUDA® plus LENVIMA® Combination Demonstrated Meaningful Tumor Response Rates in Unresectable Hepatocellular Carcinoma and Advanced Renal Cell Carcinoma
admin
-
May 29, 2020
0
Latest Pharma-News
Merck’s KEYTRUDA® Superior to Standard of Care Chemotherapy in Patients with MSI-H Colorectal Cancer
admin
-
May 29, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: Daily Roundup May 28, 2020
admin
-
May 29, 2020
0
Latest Pharma-News
FDA OK’s First Treatment for Bladder Dysfunction in children less than 2 years
admin
-
May 28, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: Daily Roundup May 27, 2020
admin
-
May 28, 2020
0
Latest Pharma-News
NICE u-turn backs Roche’s Tecentriq for small-cell lung cancer
admin
-
May 28, 2020
0
Latest Pharma-News
Roche’s OCREVUS shorter 2-hour infusion time approved
admin
-
May 28, 2020
0
Latest Pharma-News
Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir
admin
-
May 28, 2020
0
Latest Pharma-News
Novartis data highlight benefit benefits of early treatment initiation in patients with secondary progressive multiple sclerosis (SPMS)
admin
-
May 28, 2020
0
Latest Pharma-News
FDA OK’s for Johnson & Johnson’s SIRTURO® Pediatric formulation
admin
-
May 28, 2020
0
Latest Pharma-News
AbbVie Presents New Data at the European E-Congress of Rheumatology 2020
admin
-
May 28, 2020
0
Latest Pharma-News
Novartis announces new late-breaking ofatumumab data at EAN
admin
-
May 27, 2020
0
1
...
106
107
108
...
144
Page 107 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024